Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Research on AOD-9604 peptide continues to expand into models evaluating growth hormone-derived fragment behavior, peptide stability, and coordinated cellular signaling under controlled laboratory conditions
Another right granted to the patent holder is the right to grant exclusive and non-exclusive licenses to third parties
Currently, this GGG tri-agonist is in phase two clinical trials to determine its efficacy in the treatment of obesity and type 2 diabetes
Br J Pharmacol (2002) 137(3):31522
Nunnari, L
US$ 25.77
US$ 22.62
US$ 28.41
US$ 20.08
US$ 20.22
US$ 25.82
US$ 24.67
US$ 26.04
